SELENON and medical procedure: Further we also showed that the MiaPaCa-2 cells, another human pancreatic cancer cell line issued from an undifferentiated adenocarcinoma of the pancreas, was insensitive to SELN, and in part to SELN6.0 in whose the ratio raft lipids over phospholipids was fixed to 6.0.